search
Back to results

Electronic-personalized Program for Obesity in Pregnancy to Improve Delivery (ePPOP-ID)

Primary Purpose

Obesity, Pregnancy

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
ePPOP-ID program
Sponsored by
University Hospital, Lille
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Obesity focused on measuring C-section, Instrumental delivery, Pregnancy complications, Macrosomia, Neonatal complications

Eligibility Criteria

18 Years - 45 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Obese pregnant women (30 ≤ BMI < 40 kg/m2)
  • Singleton pregnancy between 12+0 to 19+6 weeks of pregnancy
  • Having an email address and an Internet access

Exclusion Criteria:

  • BMI < 30 kg/m2 or BMI > 40 kg/m2
  • History of more than 2 miscarriages
  • Severe heart disease (arrhythmias, history of myocardial infarction)
  • Multiple pregnancy
  • Unstable thyroid disease
  • Uncontrolled hypertension
  • Pre-gestational diabetes
  • Bariatric surgery
  • Any medical condition that may interfere with physical activity during pregnancy
  • No access to Internet
  • Minor
  • Absence of health insurance
  • Guardianship
  • Refusal to participate in research

Sites / Locations

  • CHU LilleRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Intervention

Control

Arm Description

personalized and online intervention. The intervention website will provide secure communication with dietician and lifestyle coaches. Women will receive emails and monthly newsletters with new content and reminder.

standard care with oral information about the goal of nutritional needs during pregnancy and gestational weight gain guidelines according to BMI

Outcomes

Primary Outcome Measures

rate of obstetrical interventions
Caesarean section and instrumental delivery (forceps and vacuum extractor)

Secondary Outcome Measures

Total gestational weight gain
Gestational hypertension
blood pressure > 140 and/or 90 mmHg after 20 weeks
Preeclampsia
gestational hypertension and proteinuria = 0.30 g/24 h
Gestational diabetes mellitus
Diagnosed by a 75g-oral glucose tolerance test (OGTT) between 24 and 28 according to French guidelines and International Association diabetic and Pregnancy Study Group
Premature birth
gestational age
Birth weight
Apgar score
Arterial umbilical cord pH
Neonatal traumatism
composite outcome (shoulder dystocia + fracture + brachial plexus injury)
Hyperbilirubinemia
Neonatal respiratory distress syndrome
Transfer in neonatal intensive care unit
Maternal fever
Thromboembolic event
Hemorrhage
Breastfeeding duration
Maternal weight
child weight

Full Information

First Posted
October 4, 2016
Last Updated
January 17, 2023
Sponsor
University Hospital, Lille
Collaborators
Ministry of Health, France
search

1. Study Identification

Unique Protocol Identification Number
NCT02924636
Brief Title
Electronic-personalized Program for Obesity in Pregnancy to Improve Delivery
Acronym
ePPOP-ID
Official Title
Electronic-personalized Program for Obesity in Pregnancy to Improve Delivery - ePPOP Study
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Recruiting
Study Start Date
November 13, 2017 (Actual)
Primary Completion Date
November 2023 (Anticipated)
Study Completion Date
November 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Lille
Collaborators
Ministry of Health, France

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to assess the efficacy of an electronic-based intervention to help pregnant overweight and obese women gain an appropriate amount of weight and improve their delivery i.e. to reduce the rate of labour procedures and interventions. We chose a composite outcome including instrumental delivery and Caesarean section, as clinically relevant outcomes because the mode of delivery is one of the major goals of the obstetrical management and is is strongly associated with body mass index and gestational weight gain.
Detailed Description
Our study is an open, multicenter, randomized, parallel-group, controlled trial. This study will include obese pregnant women recruited in 11 French university hospitals. Patients will be randomized into two-parallel groups. One group underwent the electronic-personalized program (the interventional group) and the other underwent standard care (the control group). Due to the intervention by itself, a blind study would not be achievable. Intervention group (the electronic-personalized program) The intervention will be presented as a comprehensive dietary and lifestyle intervention called "e-PPOP-ID" (electronic Personalized Programmed for Obesity in Pregnancy to Improve Delivery), including a combination of dietary, exercise, and behavioral strategies delivered on a web site. The intervention will start at the latest by 20 weeks of pregnancy throughout the pregnancy and 8 weeks post-partum. Pregnant women of the intervention group will be given an access to a personalized patient centric e-health platform. The platform we be specifically designed for this program. Various modules of this platform will be activated: - An e-learning program: An e-Learning module will propose personalized content to each patient. Before the program, patients have to fill in questionnaires about food consumption (FFQ), Eating behavior (TFEQ) and physical activity (IPAQ). The answers of these questionnaires will be taken into account to define the e-learning lessons that patients must follow.Multi educational supports such as videos, fact sheets, quiz will be integrated into this program. Patient will be motivated to validate their program thanks to a reward system (access to new content by earning stars) and their knowledge can be estimated thanks to a quiz system. Dieticians and adapted physical education teachers will develop the content.These lessons will include nutritional needs, motivational and behavioral advices, recipes, and movies of exercises easily achievable. The objective e-learning program is to limit weight gain by encouraging to healthy balance of carbohydrates, fat, protein, reducing high-energy foods intake (refined carbohydrates and saturated fats), increasing intake of fruits and vegetables and also by encouraging to physical activity. A second evaluation at around the 30th gestational weeks will allow adapting the lessons of the e-learning program, according to the progress of patients. A Social network: The platform will propose various social networking tools that can link the patient together or link the patient with the care team. Using a pseudo, patient will be able to connect together and interact with various tools such as a secured instant message system, a secured videoconference and a forum. Motivation concepts Pregnant women will receive emails, which will encourage them to log in website and follow an e-learning lessons.A newsletter will be sent every month and will link to the new contents of the web site.Adhesion of program will be measured monthly by self-questionnaire of satisfaction and by measuring the time spent on the website including the forum. Control group (Standard care): The control group will receive standard care with oral information about the goal of nutritional needs during pregnancy and gestational weight gain guidelines according to BMI.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity, Pregnancy
Keywords
C-section, Instrumental delivery, Pregnancy complications, Macrosomia, Neonatal complications

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
860 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention
Arm Type
Experimental
Arm Description
personalized and online intervention. The intervention website will provide secure communication with dietician and lifestyle coaches. Women will receive emails and monthly newsletters with new content and reminder.
Arm Title
Control
Arm Type
No Intervention
Arm Description
standard care with oral information about the goal of nutritional needs during pregnancy and gestational weight gain guidelines according to BMI
Intervention Type
Behavioral
Intervention Name(s)
ePPOP-ID program
Intervention Description
This is a personalized and online program. The website will provide secure communication with dietician and lifestyle coaches.
Primary Outcome Measure Information:
Title
rate of obstetrical interventions
Description
Caesarean section and instrumental delivery (forceps and vacuum extractor)
Time Frame
at birth
Secondary Outcome Measure Information:
Title
Total gestational weight gain
Time Frame
at birth
Title
Gestational hypertension
Description
blood pressure > 140 and/or 90 mmHg after 20 weeks
Time Frame
at birth
Title
Preeclampsia
Description
gestational hypertension and proteinuria = 0.30 g/24 h
Time Frame
at birth
Title
Gestational diabetes mellitus
Description
Diagnosed by a 75g-oral glucose tolerance test (OGTT) between 24 and 28 according to French guidelines and International Association diabetic and Pregnancy Study Group
Time Frame
at birth
Title
Premature birth
Time Frame
at birth
Title
gestational age
Time Frame
at birth
Title
Birth weight
Time Frame
at birth
Title
Apgar score
Time Frame
at birth
Title
Arterial umbilical cord pH
Time Frame
at birth
Title
Neonatal traumatism
Description
composite outcome (shoulder dystocia + fracture + brachial plexus injury)
Time Frame
at birth
Title
Hyperbilirubinemia
Time Frame
1st week after birth
Title
Neonatal respiratory distress syndrome
Time Frame
1st week after birth
Title
Transfer in neonatal intensive care unit
Time Frame
1st week after birth
Title
Maternal fever
Time Frame
1st week after delivery
Title
Thromboembolic event
Time Frame
1st week after delivery
Title
Hemorrhage
Time Frame
1st week after delivery
Title
Breastfeeding duration
Time Frame
8 weeks +/- 2 weeks after delivery
Title
Maternal weight
Time Frame
8 weeks +/- 2 weeks after delivery
Title
child weight
Time Frame
8 weeks +/- 2 weeks after delivery

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Obese pregnant women (30 ≤ BMI < 40 kg/m2) Singleton pregnancy between 12+0 to 19+6 weeks of pregnancy Having an email address and an Internet access Exclusion Criteria: BMI < 30 kg/m2 or BMI > 40 kg/m2 History of more than 2 miscarriages Severe heart disease (arrhythmias, history of myocardial infarction) Multiple pregnancy Unstable thyroid disease Uncontrolled hypertension Pre-gestational diabetes Bariatric surgery Any medical condition that may interfere with physical activity during pregnancy No access to Internet Minor Absence of health insurance Guardianship Refusal to participate in research
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Philippe Deruelle, MD,PhD
Phone
+33 320446307
Ext
+33
Email
philippe.deruelle@chru-lille.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Philippe Deruelle, MD, PhD
Organizational Affiliation
University Hospital, Lille
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU Lille
City
Lille
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sylvie Deghilage
Phone
0320446467
Email
sylvie.deghilage@chru-lille.fr
First Name & Middle Initial & Last Name & Degree
Sandy Hanssens, MD

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
33028261
Citation
Deruelle P, Lelorain S, Deghilage S, Couturier E, Guilbert E, Berveiller P, Senat MV, Vayssiere C, Sentilhes L, Perrotin F, Gallot D, Chauleur C, Sananes N, Roth E, Luton D, Caputo M, Lorio E, Chatelet C, Couster J, Timbely O, Doret-Dion M, Duhamel A, Pigeyre M. Rationale and design of ePPOP-ID: a multicenter randomized controlled trial using an electronic-personalized program for obesity in pregnancy to improve delivery. BMC Pregnancy Childbirth. 2020 Oct 7;20(1):602. doi: 10.1186/s12884-020-03288-x.
Results Reference
derived

Learn more about this trial

Electronic-personalized Program for Obesity in Pregnancy to Improve Delivery

We'll reach out to this number within 24 hrs